NeuroPace (NPCE) Cash from Investing Activities (2020 - 2026)
NeuroPace (NPCE) posted Cash from Investing Activities of -$125000.0 for Q2 2026, down 6.84% on a QoQ basis from -$117000.0 in Q1 2026, and up 25.6% year-over-year from -$99526.1 in Q2 2025.
Analysis
NeuroPace (NPCE) Cash from Investing Activities (2020 - 2026) Analysis & Trends
NeuroPace has reported Cash from Investing Activities for 7 years, with the latest figure at -$125000.0 in Q2 2026.
- On a quarterly basis, Cash from Investing Activities rose 25.6% year-over-year to -$125000.0 in Q2 2026; TTM through Jun 2026 was -$369000.0, a 111.69% decrease from a year earlier, with the FY2025 full-year figure at -$332000.0, down 103.69% from the prior year.
- Cash from Investing Activities was -$125000.0 for Q2 2026 at NeuroPace, down from -$117000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $10.1 million in Q1 2023, with the low at -$306000.0 in Q1 2022.
- Average Cash from Investing Activities over 5 years is $3.1 million, with a median of $2.2 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities soared 5877.92% in 2022, then tumbled 216.22% in 2026.
- Over 5 years, Cash from Investing Activities stood at $8.9 million in 2022, then plunged by 61.02% to $3.5 million in 2023, then plunged by 43.45% to $2.0 million in 2024, then sank by 104.95% to -$97000.0 in 2025, then retreated by 28.87% to -$125000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$125000.0 (Q2 2026), -$117000.0 (Q1 2026), and -$97000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | -125,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -125,000.00 |
| Mar 31, 2026 | -117,000.00 |
| Dec 31, 2025 | -97,000.00 |
| Sep 30, 2025 | -30,000.00 |
| Jun 30, 2025 | -168,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 4.19 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Mar 31, 2023 | 10.07 Mn |
| Dec 31, 2022 | 8.90 Mn |
| Sep 30, 2022 | 6.97 Mn |
| Jun 30, 2022 | 8.24 Mn |
| Mar 31, 2022 | -306,000.00 |
| Dec 31, 2021 | -154,000.00 |
| Sep 30, 2021 | -190,000.00 |